Healthcare -
Medical - Devices - NASDAQ - US
$ 4.245
-1.28 %
$ 547 M
Market Cap
-84.9
P/E
Price Target
Average
117.90%
Revenue Forecast
Estimate
17.98%
EBIT
Estimate
39.31%
Net Income
Estimate
67.18%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytek Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CTKB of $9.25 , with forecasts ranging from
a
low of
$5.25 to a high of $16 .
CTKB Lowest Price Target
Wall Street Target
5.25 USD
23.67%
CTKB Average Price Target
Wall Street Target
9.25 USD
117.90%
CTKB Highest Price Target
Wall Street Target
16 USD
276.91%
REVENUE FORECAST
Revenue Forecast Chart CTKB
EBIT FORECAST
EBIT Forecast Chart CTKB
NET INCOME FORECAST
Net Income Chart CTKB